Krilogy Financial’s X4 Pharmaceuticals XFOR Stock Holding History

Krilogy Financial’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1	Closed	-$5K	–	641
2018 Q1	$5K	Buy	+1	New	+$2.91K	﹤0.01%	608

Other funds holding XFOR

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Krilogy Financial's XFOR Position: Q2 2018 in Review

Krilogy Financial sold out of X4 Pharmaceuticals (XFOR) in Q2 2018, closing a stake of 1 share — an estimated $5K sold.

Krilogy Financial first reported a position in XFOR in Q1 2018 and held it in 1 quarter. The position peaked at $5K in Q1 2018. 35 funds tracked by Wall St. Rank hold XFOR as of Q2 2018.

Krilogy Financial reported no remaining X4 Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Krilogy Financial sold 1 X4 Pharmaceuticals share in Q2 2018, an estimated $5K.
Krilogy Financial first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 1 quarter.
Krilogy Financial's X4 Pharmaceuticals position peaked at $5K in Q1 2018.
35 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2018.

Based on Krilogy Financial's 13F filing for Q2 2018, filed 15 Aug 2018.